T. Rowe Price Associates’s Red Violet RDVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Buy
22,524
+4,618
+26% +$219K ﹤0.01% 2160
2026
Q1
$620K Buy
17,906
+4,670
+35% +$205K ﹤0.01% 2356
2025
Q4
$754K Buy
13,236
+680
+5% +$36.9K ﹤0.01% 2210
2025
Q3
$657K Buy
12,556
+513
+4% +$24.3K ﹤0.01% 2263
2025
Q2
$593K Buy
12,043
+3,329
+38% +$145K ﹤0.01% 2224
2025
Q1
$328K Sell
8,714
-18,963
-69% -$714K ﹤0.01% 2425
2024
Q4
$1M Buy
+27,677
New +$922K ﹤0.01% 1967

Other funds holding RDVT

T. Rowe Price Associates's RDVT Position: Q2 2026 in Review

T. Rowe Price Associates increased its Red Violet (RDVT) stake by 26% in Q2 2026, buying an estimated $219K and bringing the position to 22,524 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

T. Rowe Price Associates first reported a position in RDVT in Q4 2024 and has held it in 7 quarters since. 173 funds tracked by Wall St. Rank hold RDVT as of Q2 2026.

  • T. Rowe Price Associates held 22,524 shares of Red Violet worth $1.44M as of Q2 2026.
  • T. Rowe Price Associates bought 4,618 Red Violet shares in Q2 2026, an estimated $219K.
  • Red Violet made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2160 holding.
  • T. Rowe Price Associates first reported a position in Red Violet in Q4 2024 and has held it in 7 quarters since.
  • 173 funds tracked by Wall St. Rank held Red Violet as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.